A carregar...
REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB
<em>The review of safety of monoclonal anti-ige-antibodies (xolair) — a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
"Paediatrician" Publishers LLC
2008-01-01
|
Colecção: | Voprosy Sovremennoj Pediatrii |
Acesso em linha: | http://vsp.spr-journal.ru:80/jour/article/view/1462 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|